Organizations must lead with privacy and ethics when researching and implementing neurotechnology: FPF and IBM Live event and report release
A New FPF and IBM Report and Live Event Explores Questions About Transparency, Consent, Security, and Accuracy of Data
The Future of Privacy Forum (FPF) and the IBM Policy Lab released recommendations for promoting privacy and mitigating risks associated with neurotechnology, specifically with brain-computer interface (BCI). The new report provides developers and policymakers with actionable ways this technology can be implemented while protecting the privacy and rights of its users.
“We have a prime opportunity now to implement strong privacy and human rights protections as brain-computer interfaces become more widely used,” said Jeremy Greenberg, Policy Counsel at the Future of Privacy Forum. “Among other uses, these technologies have tremendous potential to treat people with diseases and conditions like epilepsy or paralysis and make it easier for people with disabilities to communicate, but these benefits can only be fully realized if meaningful privacy and ethical safeguards are in place.”
Brain-computer interfaces are computer-based systems that are capable of directly recording, processing, analyzing, or modulating human brain activity. The sensitivity of data that BCIs collect and the capabilities of the technology raise concerns over consent, as well as the transparency, security, and accuracy of the data. The report offers a number of policy and technical solutions to mitigate the risks of BCIs and highlights their positive uses.
“Emerging innovations like neurotechnology hold great promise to transform healthcare, education, transportation, and more, but they need the right guardrails in place to protect individuals’ privacy,” said IBM Chief Privacy Officer Christina Montgomery. “Working together with the Future of Privacy Forum, the IBM Policy Lab is pleased to release a new framework to help policymakers and businesses navigate the future of neurotechnology while safeguarding human rights.”
FPF and IBM have outlined several key policy recommendations to mitigate the privacy risks associated with BCIs, including:
- Rethinking transparency, notice, terms of use, and consent frameworks to empower people around uses of their neurodata;
- Ensuring that BCI devices are not allowed for uses to influence decisions about individuals that have legal effects, livelihood effects, or similar significant impacts—such as assessing the truthfulness of statements in legal proceedings; inferring thoughts, emotions or psychological state, or personality attributes as part of hiring or school admissions decisions; or assessing individuals’ eligibility for legal benefits;
- Promoting an open and inclusive research ecosystem by encouraging the adoption of open standards for the collection and analysis of neurodata and the sharing of research data with appropriate safeguards in place.
- Policymakers and other BCI stakeholders should carefully evaluate how existing policy frameworks apply to neurotechnologies and identify potential areas where existing laws and regulations may be insufficient for the unique risks of neurotechnologies.
FPF and IBM have also included several technical recommendations for BCI devices, including:
- Providing hard on/off controls for users;
- Allowing users to manage the collection, use, and sharing of personal neurodata on devices and in companion apps;
- Offering heightened transparency and control for BCIs that send signals to the brain, rather than merely receive neurodata;
- Utilizing best practices for privacy and security to store and process neurodata and use privacy enhancing technologies where appropriate; and
- Encrypting sensitive personal neurodata in transit and at rest.
FPF-curated educational resources, policy & regulatory documents, academic papers, thought pieces, and technical analyses regarding brain-computer interfaces are available here.
Read FPF’s four-part series on Brain-Computer Interfaces (BCIs), providing an overview of the technology, use cases, privacy risks, and proposed recommendations for promoting privacy and mitigating risks associated with BCIs.